Damora Therapeutics, Inc. · NASDAQ:DMRA
BlackRock, Inc. reported a 5.10% stake in Damora Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 28, 2026
BlackRock, Inc. reported a 5.10% stake in Damora Therapeutics, Inc., 3,143,576 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,143,576
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.10% | 3,143,576 |
Source
Related
- Damora Therapeutics, Inc.
- BlackRock, Inc.
- Damora Therapeutics, Inc. shareholders
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026